scorecardresearch
Add as a preferred source on Google
Saturday, January 10, 2026
TopicCipla

Topic: Cipla

New injectable to treat complex, antibiotic-resistant UTIs now in India. All about plazomicin

Prevalence of UTIs in Indian population is estimated to be around 33%. Men have less than 15% chance of developing this infection in their lifetime compared to 60% in case of women.

Cipla set to bring Afrezza, 1st inhalable insulin since Exubera, to Indian markets by 2025

Afrezza, world’s only rapid-acting, inhaled insulin for type 1 & type 2 diabetes patients & manufactured by MannKind, received CDSCO approval this week.

Who is Jasdeep Singh Gill, new spiritual head of Punjab’s powerful Dera Beas

An IIT Delhi and Cambridge alumnus, Gill will take over from Gurinder Singh Dhillon. Dera Radha Soami Satsang Beas wields significant influence in Punjab.

Cipla’s US unit recalls 6 bronchospasm inhaler batches over container defect

Cipla advises consumers to discontinue use, return or discard the inhalers, and report any adverse reactions to the U.S. health agency.

On Camera

Global economic growth to slow in 2026 as Trump’s tariffs bite, UN says

The global economy is forecast to expand 2.7% this year, down from an estimated 2.8% in 2025. Growth is expected to go back up to 2.9% by 2027.

2025: Pakistan’s deadliest year in over a decade

Islamabad-based think-tank PICSS's new report says Pakistan saw 'pronounced escalation' in violence last year, with 3,413 conflict-related deaths compared to 1,950 in previous year.

A year-end Mea Culpa in National Interest—The Army-Islam combo doesn’t kill democracy

Many of you might think I got something so wrong in National Interest pieces written this year. I might disagree! But some deserve a Mea Culpa. I’d deal with the most recent this week.